全文获取类型
收费全文 | 751篇 |
免费 | 67篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 79篇 |
妇产科学 | 7篇 |
基础医学 | 116篇 |
口腔科学 | 6篇 |
临床医学 | 46篇 |
内科学 | 155篇 |
皮肤病学 | 12篇 |
神经病学 | 55篇 |
特种医学 | 12篇 |
外科学 | 132篇 |
综合类 | 10篇 |
预防医学 | 31篇 |
眼科学 | 11篇 |
药学 | 105篇 |
中国医学 | 5篇 |
肿瘤学 | 30篇 |
出版年
2023年 | 11篇 |
2022年 | 10篇 |
2021年 | 22篇 |
2020年 | 20篇 |
2019年 | 9篇 |
2018年 | 16篇 |
2017年 | 15篇 |
2016年 | 21篇 |
2015年 | 25篇 |
2014年 | 33篇 |
2013年 | 47篇 |
2012年 | 69篇 |
2011年 | 68篇 |
2010年 | 37篇 |
2009年 | 35篇 |
2008年 | 35篇 |
2007年 | 46篇 |
2006年 | 52篇 |
2005年 | 29篇 |
2004年 | 32篇 |
2003年 | 16篇 |
2002年 | 17篇 |
2001年 | 13篇 |
2000年 | 12篇 |
1999年 | 13篇 |
1998年 | 4篇 |
1997年 | 6篇 |
1996年 | 3篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 12篇 |
1992年 | 13篇 |
1991年 | 14篇 |
1990年 | 6篇 |
1989年 | 2篇 |
1988年 | 10篇 |
1987年 | 6篇 |
1984年 | 4篇 |
1978年 | 3篇 |
1974年 | 3篇 |
1971年 | 3篇 |
1968年 | 2篇 |
1967年 | 3篇 |
1965年 | 1篇 |
1964年 | 1篇 |
1957年 | 2篇 |
1925年 | 1篇 |
1919年 | 2篇 |
1918年 | 1篇 |
1916年 | 1篇 |
排序方式: 共有820条查询结果,搜索用时 15 毫秒
81.
Dr. Anupama Chawla MD Peter I. Karl PhD Rosandra N. Reich Gopal Narasimhan Gregory A. Michaud Stanley E. Fisher MD Benjamin L. Schneider MD 《Digestive diseases and sciences》1995,40(5):943-948
Olsalazine (OLZ), a relatively new form of 5-aminosalicylic acid (5-ASA), is being used for the treatment of colitis. A major side effect of olsalazine is diarrhea, reported in 12–25% of patients. One suggested mechanism for this side effect is enhanced ileal water and electolyte secretion. We propose that OLZ may also inhibit ileal bile acid (BA) transport, resulting in choleretic diarrhea. This would result in excess BAs reaching the colon, with consequent BA-induced secretory diarrhea. Therefore, we studied the effect of OLZ on rat ileal absorption of taurocholate. BA uptake was determined in rat ileal segments, everted sacs, brush border membrane vesicles (BBMV), andXenopus laevis oocytes. Segments and everted sacs were treated with 5 mM OLZ for 30 min prior to and throughout 10-min taurocholate (Tc) uptake. Terminal ileal BBMV were used to study the effect of OLZ on sodium-dependent bile acid uptake independent of cellular metabolism. Direct effects on the bile acid carrier were examined usingXenopus laevis oocytes expressing the cloned apical rat ileal BA transporter. In ileal segments 5 mM OLZ inhibited 10-min Tc uptake by 69.4±8.8% (P<0.01) (N=10 animals). Increasing concentrations of OLZ resulted in a dose-dependent inhibition of Tc uptake. Ten-minute Tc uptake with 0.5, 1.0, 2.0, 2.5, and 5 mM OLZ was inhibited by 13.5, 39.6, 49.7, and 70.5%, respectively. In BBMV, OLZ inhibited 45-sec Tc uptake in a dose-dependent manner but did not effect Na-dependentl-alanine uptake. Kinetic analysis revealed a noncompetitive inhibition by 2 mM olsalazine. Olsalazine, 5 mM, also inhibited Na-dependent uptake of Tc into oocytes, which expressed the rat ileal sodium-dependent bile acid transporter (8.0±3.7 vs 2.6±2.0 pmol/oocyte/hr,P<0.001). OLZ inhibits sodium-dependent Tc uptake and transmucosal transport in the rat ileum in a dose-dependent manner. This inhibition is relatively specific, noncompetitive, and does not require intact cellular mechanisms. This effect of OLZ on ileal function may contribute to the diarrhea frequently observed with this drug.Supported in part by a grant from Reach Out For Youth with IBD and a gift from Ruth & Leonard Litwin and by grants from the National Institute of Health (DK02076,34989,43509, HD07388, HD20632 and HD27757).This work was presented in part at the American Gastroenterological Association meeting, Boston, Massachusetts, May 19, 1993.Address for reprint requests: Dr. Anupama Chawla, Pediatric Gastroenterology, North Shore University Hospital-Cornell University Medical College, 300 Community Drive, Manhasset, New York 11030. 相似文献
82.
Jordana Kron William Sauer Gisela Mueller Joseph Schuller Frank Bogun Sinan Sarsam Lynda Rosenfeld Teferi Y. Mitiku Joshua M. Cooper Davendra Mehta Arnold J. Greenspon Matthew Ortman David B. Delurgio Ravinder Valadri Calambur Narasimhan Nalla Swapna Jagmeet P. Singh Stephan Danik Steven M. Markowitz Adrian K. Almquist Andrew D. Krahn Luke G. Wolfe Shawn Feinstein Kenneth A. Ellenbogen Thomas Crawford 《Journal of interventional cardiac electrophysiology》2015,43(1):55-64
83.
James W. Nelson Narasimhan Sudarsan Grace E. Phillips Shira Stav Christina E. Lünse Phillip J. McCown Ronald R. Breaker 《Proceedings of the National Academy of Sciences of the United States of America》2015,112(17):5389-5394
Major changes in bacterial physiology including biofilm and spore formation involve signaling by the cyclic dinucleotides c-di-GMP and c-di-AMP. Recently, another second messenger dinucleotide, c-AMP-GMP, was found to control chemotaxis and colonization by Vibrio cholerae. We have identified a superregulon of genes controlled by c-AMP-GMP in numerous Deltaproteobacteria, including Geobacter species that use extracellular insoluble metal oxides as terminal electron acceptors. This exoelectrogenic process has been studied for its possible utility in energy production and bioremediation. Many genes involved in adhesion, pilin formation, and others that are important for exoelectrogenesis are controlled by members of a variant riboswitch class that selectively bind c-AMP-GMP. These RNAs constitute, to our knowledge, the first known specific receptors for c-AMP-GMP and reveal that this molecule is used by many bacteria to control specialized physiological processes.Three major types of cyclic dinucleotide second messengers have been discovered in biological systems. The first to be found was c-di-GMP (Fig. 1A, Top), which serves as a regulator of diverse physiological changes in most bacterial lineages (1). The second, c-di-AMP (2), is an important signaling compound during bacterial sporulation and germination (3) and has also been found to regulate osmotic shock responses in Gram-positive bacteria (4, 5). More recently, a third type of cyclic dinucleotide called c-AMP-GMP (Fig. 1A, Bottom) was found to be required for Vibrio cholera virulence (6).Open in a separate windowFig. 1.Selective recognition of c-AMP-GMP by a natural aptamer. (A) Chemical structures of c-di-GMP and c-AMP-GMP. (B) Sequence and secondary structure of the 100 erfK RNA from G. metallireducens. P1, P2, and P3 identify base-paired substructures. M1 designates a mutant construct wherein position 20 is changed to G. Regions of constant, decreasing, and increasing RNA cleavage upon addition of ligand are indicated by yellow, red, and green circles, respectively. The arrowhead indicates the start of the RNA structure stability data derived from C. (C) PAGE analysis of in-line probing assays of 5′ 32P-labeled 100 erfK in the presence (10 µM) of various cyclic dinucleotides. NR, T1, and ‒OH designate lanes loaded with precursor RNA (Pre), RNA partially digested with RNase T1 (resulting in cleavage after G residues), and RNA partially digested with alkali (resulting in cleavage after every residue). Several RNase T1 cleavage product bands are labeled. Regions undergoing substantial change in spontaneous cleavage rates are labeled 1–4. The inosine-based analog of c-di-GMP is labeled c-di–IMP. (D) Plot of the fraction of riboswitch bound to ligand versus the log of the molar concentration (c) of the ligand. Data are derived from Fig. S2, and each point is the average of the normalized fraction of modulation at sites 1 and 2. Error bars indicate the SD of the average. Included are theoretical curves expected for one-to-one interaction between ligand and RNA for the KD values given.Although bacterial c-AMP-GMP is formed via two 3′,5′-phosphodiester linkages, metazoans produce an analog with one 2′,5′-phosphodiester linkage and one 3′,5′-phosphodiester linkage (7–9). This natural structural variant has been identified as important for triggering innate immune responses in metazoans (7–11). Far greater diversity of cyclic dinucleotides is possible by varying either the nucleotide composition or the manner in which dinucleotides are joined. Therefore, many additional types of cyclic dinucleotides might await discovery in nature where they might regulate other critical cellular processes.Our approach to uncovering the chemical structures and biological functions of cyclic dinucleotide signaling compounds is to discover their RNA receptors. Three different riboswitch receptor classes have already been discovered that respond to c-di-GMP (12, 13) and c-di-AMP (5). Riboswitches are structured noncoding RNA (ncRNA) domains that selectively bind a small molecule or ion and thereby trigger a change in the expression of associated genes (14, 15). The majority of riboswitch ligands are composed of or derived from nucleotides, which supports the hypothesis that RNA-based metabolites and their riboswitch partners might descend from primordial RNA world organisms (16). If true, then cyclic dinucleotides and their receptors might be modern reflections of ancient signaling pathways. Regardless of their origins, the discovery of each new regulatory RNA motif that selectively recognizes a second messenger also reveals a superregulon for the signaling compound and the biology that it controls (5, 12, 13).Given that the diversity of natural cyclic dinucleotides might be greater than is currently known, and given that some riboswitch classes have undergone subtle changes to adapt to different ligands (17–20), we re-examined known cyclic dinucleotide riboswitch classes and their associated genes for evidence of unidentified ligands or riboswitch classes. Of special interest were those RNAs that both carry mutations in the core of the ligand-binding aptamer and have gene associations considered unusual for the parent riboswitch class. Through these efforts, we identified a subset of riboswitches within the c-di-GMP-I riboswitch class (12) that we hypothesized might bind a different ligand. In the current study, we demonstrate that these riboswitches recognize c-AMP-GMP and control a set of genes that are important for the utilization of iron(III) oxide in exoelectrogenesis. 相似文献
84.
STUDY OBJECTIVES: The use of highly active antiretroviral therapy (HAART) has dramatically improved morbidity and mortality in patients with HIV infection. The types of critical illness and their outcomes in HIV-infected patients in recent years is unknown. DESIGN: We reviewed the medical records of all patients admitted to the Medical ICU of Beth Israel Medical Center, NY, from January to June 2001 and compared their characteristics with patients admitted to the same unit from November 1991 to October 1992. RESULTS: Of 441 admissions in the first half of 2001, 63 admissions (14%) were in 53 HIV-seropositive patients. There were 65 admissions to the Medical ICU during the 1-year period spanning 1991 to 1992. Compared with the earlier period, the 2001 patients were more likely to be black (52% vs 26%, respectively; p < 0.01) and injection drug users (75% vs 48%, respectively; p < 0.01), and were less likely to be white (11% vs 23%, respectively; difference not significant) and homosexual men (6% vs 26%, respectively; p < 0.01). In 2001, patients were less likely to be admitted with respiratory failure (22% vs 54%, respectively; p < 0.01) and with Pneumocystis jiroveci pneumonia (formerly referred to as Pneumocystis carinii) [3% vs 34%, respectively; p < 0.001], and were more likely to be admitted with non-HIV-related diseases (67% vs 12%, respectively; p < 0.001). Overall survival was much higher in the later period (71% vs 49%, respectively; p < 0.01). CONCLUSIONS: In the era of HAART, more patients with HIV infection were admitted to the ICU over a 12-month period than were 10 years previously. Patients were more likely to be injection drug users and were more likely to be admitted to the ICU because of non-HIV-associated conditions. 相似文献
85.
Paolo Alboni Narasimhan Shantha Roberto Pirani Franco Baggioni Salvatore Scarfo Anna Maria Tomasi Antonio Masoni 《The American journal of cardiology》1984,53(1):93-98
This study evaluates whether the electrophysiologic effects of i.v. amiodarone in patients with reentrant supraventricular tachycardia (SVT) can predict the efficacy of long-term oral therapy with this drug. The effects of oral and i.v. amiodarone were studied in 27 patients with SVT. In 14 the SVT circuit involved a concealed atrioventricular bypass for retrograde conduction (Group I), and in 13 a concealed atrio-His bypass (Group II). Intravenous amiodarone induced significant prolongation of the AH interval, the refractory periods of the atrium, atrioventricular node, His-Purkinje system and ventricular myocardium. The ventriculoatrial interval was slightly prolonged in Group I patients and did not change in Group II patients after i.v. administration of the drug. In both groups, the effective refractory period (ERP) of the concealed bypass was prolonged by i.v. amiodarone.During control state, SVT could be induced in all patients; after i.v. administration of the drug, SVT was presented in 6 patients in Group I and in 8 patients in Group II. In all cases, in which i.v. amiodarone prolonged the ERP of the concealed bypass to more than 350 ms, the drug always prevented SVT even when given orally. All but 2 patients—1 from Group I and 1 from Group II—remained asymptomatic after oral amiodarone. In the patient from Group I, SVT had been prevented by i.v. amiodarone, whereas in the patient from Group II SVT could not be induced by ventricular stimulation during the control state, but appeared after i.v. administration of the drug.These data indicate that (1) therapy with oral amiodarone is effective in most patients with SVT irrespective of the type of bypass fibers, i.e., atrio-His or Kent bundle; (2) effective suppression of induction of SVT with i.v. amiodarone is a predictor of efficacy of amiodarone in 93 % of the cases. However, a lack of response to i.v. amiodarone is not a predictor of lack of efficacy of oral amiodarone; (3) prolongation of the ERP of the concealed bypass tract to > 350 ms appears to have a favorable predictive value in oral administration; (4) a change in the inducibility of SVT after i.v. amiodarone appears to have a negative predictive value in controlling SVT with the oral drug. 相似文献
86.
David T. Wong MD Jaisy J. Yang BHSc Hannah Y. Mak MSc Narasimhan Jagannathan MD 《Journal canadien d'anesthésie》2012,59(7):704-715
Purpose
This article is a narrative review regarding the usage and effectiveness of introducers or catheters to facilitate tracheal intubation through a supraglottic airway (SGA) as an alternative intubation technique in normal and difficult airway management.Sources
Relevant articles were obtained through Medline (1948-July 2011). The articles were subsequently cross-referenced for additional literature, and only articles published in English were included.Principal findings
In this review, we consider 32 reports using the LMA Classic?, LMA Unique?, LMA ProSeal?, LMA Supreme?, AuraOnce?, and i-gel? as SGA conduits for intubation. In 13 articles, the use of an Aintree Intubation Catheter was described as an intubation introducer and resulted in high success rates in both elective and emergent situations. Eight studies used a guidewire exchange catheter technique. Although blind intubation using a guidewire resulted in a high failure rate, these studies found that using a bronchoscope improved successful intubation. Ten studies showed that insertion of a gum elastic bougie with a bronchoscope as an intubation introducer has high success rates compared with blind bougie insertion. One article described the use of a small endotracheal tube as an intermediary for tracheal intubation.Conclusions
In failed intubation scenarios, supraglottic airways, such as the LMA Classic? or LMA ProSeal? can serve as a conduit for tracheal intubation. A number of techniques using introducers or catheters can facilitate the insertion of an adequately sized endotracheal tube, particularly guided by a bronchoscope. Usage of introducers or catheters through a supraglottic airway may be a useful alternative intubation technique in difficult airway management. 相似文献87.
Pallavi A. Kathare Kalyan S. Muthuswamy Jaishankar Sadasivan Narasimhan Calumbar Nageswara Rao Koneti 《Indian heart journal》2013,65(1):111-113
We report a case of incessant ventricular tachycardia managed successfully with medications. The transthoracic echocardiogram showed multiple cardiac rhabdomyomas involving ventricular free wall and outflow tracts. Computerized tomography of brain showed multiple subependymal tubers confirming Tuberous Sclerosis. The follow up assessment showed sinus rhythm and regressing cardiac rhabdomyomas. 相似文献
88.
89.
90.
Malairajan P Gopalakrishnan G Narasimhan S Veni KJ Kavimani S 《Journal of ethnopharmacology》2007,110(2):348-351
The ethanol extract of Toona ciliata Roemer (heart wood) was evaluated for its anti-ulcer activity against aspirin plus pylorous ligation induced gastric ulcer (antisecretory), HCl-ethanol induced ulcer (cytoprotective) and water immersion stress induced ulcer in rats. We found that Toona ciliata extract at a dose of 300mg/kg p.o. markedly decrease the incidence of ulcers in all the three models. Ethanol extract of Toona ciliata showed significant reduction in gastric volume, free acidity, total acidity and ulcer index. The plant extract also showed gastro protective activity (52.94%), whereas standard drug sucralfate showed 94.85%. Toona ciliata extract showed protection index 43.0% in water immersion stress induced ulcer, whereas standard drug omeprazole showed protection index 100%. 相似文献